Pharma EquityPharma Equity Group’s Notification from the EPO Granting Their Patent for the Drug Candidate RNX-022 - Analyst Group
Pharma Equity Group (“PEG” or “the Company”) announced on Tuesday, March 5th, that the Company’s sub...
Analyst Group•05 mar 2024 12:50